Nov 10 2024
Steven Chen, MD, MPH, FAAD interviewed by Carlos Garcia, MD commentary by Eryn Patin, BS and Sarah D. Ferree, MD with Benjamin Stoff, MD, FAAD (ed.)
Immune checkpoint inhibitors have revolutionized cancer therapeutics. While this new class is highly effective in treating cancer, it has been noted to cause various immune-related adverse events to multiple organ systems including the skin. Join Steven Chen, MD, MPH, FAAD and Carlos Garcia, MD to learn more about these adverse events and how dermatologists should manage them.
CME Information
The information provided in this CME activity is for continuing education purposes only, it is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition.